Scientific Publications

favicon.png
Download the pdf
캡처.JPG
As part of its global investment case for oral cholera vaccines, IVI developed a Bangladesh case study providing a local perspective. The report provides an estimate of the disease and economic burden, as well as financing needs, likely challenges, and cost, impact and cost-effectiveness estimates for several cholera vaccination strategies.
캡처.JPG
This report gives a summary of the pilot introduction of Vi polysaccharide typhoid vaccine in Nepal through school-based vaccination programs conducted in Lalitpur and Bhaktapur Districts. The Vi-based Vaccines for Asia (VIVA) Initiative, part of IVI's Typhoid Program, helped to coordinate pilot immunization campaigns in two sectors in Nepal - schools and the tourism industry - in order to accelerate the introduction of the Vi polysaccharide vaccine in high-risk areas.
캡처.JPG
This report gives a summary of the pilot introduction of Vi polysaccharide typhoid vaccine in Nepal through a tourism sector vaccination campaign. The Vi-based Vaccines for Asia (VIVA) Initiative, part of IVI's Typhoid Program, helped to coordinate pilot immunization campaigns in two sectors in Nepal - schools and the tourism industry - in order to accelerate the introduction of the Vi polysaccharide vaccine in high-risk areas.
캡처.JPG
    IVI developed an investment case in order to provide a global evidence base for investing in oral cholera vaccines as part of a larger strategy that includes improvements to water, sanitation, and hygiene. This report was designed to meet the needs of groups that include the WHO Strategic Advisory Group of Experts on Immunization (SAGE), the international health community, vaccine manufacturers, prospective donor agencies, and policymakers from cholera-endemic countries for more information about the potential demand for cholera vaccines, the cost involved to meet this demand, and the impact and cost-effectiveness of vaccination.